Echo Pharmaceuticals is a specialist pharmaceutical company aiming to meet patient needs in a wide range of therapeutic areas. Our development programs focus on a product portfolio of cannabinoid based medicines, including the world’s first natural THC tablet, Namisol®, and drug delivery technologies, including the novel lipophilic compound delivery technology, Alitra™.
     
home1.jpg
                      
home2.jpg

Echo News

06/10/11 First Chronic Pancreatitis patient dosed with NamisolĀ® On 06 October 2011 the first patient with chronic pancreati... more

21/09/11 First Alzheimer patient dosed with NamisolĀ® On 21 September 2011 the first patient with dementia was do... more

08/09/11 Echo Pharmaceuticals proud sponsor of the IAMC conference in Bonn Echo Pharmaceuticals is sponsor of the IACM (International ... more

In the Spotlight